Gene · 3416
Papers2,652
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,652
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanistic modeling of amyloid dynamics relating to Alzheimer's disease progression. | Front Aging Neurosci | 2026 | 41743468 | PubTator, text mining | PubMed |
| Intranasal CM-hMSCs modulate brain gene expression linked to glucose metabolism and inflammation in male and female rats exposed to maternal and post-weaning high-fat diets. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 41670689 | PubTator, text mining | PubMed |
| APP-C31 pathology as a target in neurodegenerative diseases. | J Biomed Sci | 2026 | 41639863 | PubTator, text mining | PubMed |
| Overweight and obesity association with mortality in patients with heart failure and reduced or preserved ejection fraction-a cohort study. | PLoS One | 2026 | 41632717 | PubTator, text mining | PubMed |
Development of novel salicylic acid derivatives with dual anti-inflammatory and anti-arthritic potentials: synthesis, in vitro bio-evaluation, and in silico toxicity prediction with molecular modeling simulations. | RSC Adv | 2026 | 41550833 | PubTator, text mining | PubMed |
| Oxidative stress-driven transcriptomic remodeling in human astrocytes reveals network signatures associated with neurodegenerative and cardiovascular processes. | Comput Struct Biotechnol J | 2026 | 41550140 | PubTator, text mining | PubMed |
| Effect of blood acidification on hemolysis-induced insulin degradation. | Clin Chim Acta | 2026 | 41371327 | PubTator, text mining | PubMed |
| Research Progress on Idebenone in Neurodegenerative Diseases. | Aging Med (Milton) | 2025 | 41531784 | PubTator, text mining | PubMed |
| It Takes Two to Tango: Current Understanding of the Role of M16 Family of Proteases and Their Structural Properties. | Biomolecules | 2025 | 41463353 | PubTator, text mining | PubMed |
| Insulin-degrading enzyme confers neuroprotection in Parkinson's disease by inhibiting the Hippo signaling pathway. | Cell Death Dis | 2025 | 41136383 | PubTator, text mining | PubMed |
| Exosome/Extracellular Vesicles-Based Therapeutics in Alzheimer's Disease: Neuroprotective Roles and Future Perspectives. | J Mol Neurosci | 2025 | 41076604 | PubTator, text mining | PubMed |
| Protective Effects of Coixol Against Nε-Carboxymethyllysine-Induced Injury in IMR-32 Neuronal Cells: Modulation of Endoplasmic Reticulum Stress and Amyloidogenic Pathways. | Nutrients | 2025 | 41010465 | PubTator, text mining | PubMed |
| From metabolic dysregulation to neurodegenerative pathology: the role of hyperglycemia, oxidative stress, and blood-brain barrier breakdown in T2D-driven Alzheimer's disease. | Metab Brain Dis | 2025 | 41003796 | PubTator, text mining | PubMed |
| Dimerization and dynamics of human angiotensin-I converting enzyme revealed by cryo-EM and MD simulations. | Elife | 2025 | 40988601 | PubTator, text mining | PubMed |
| Potential Mitochondria-Related Key Genes in Post-Traumatic Stress Disorder Analyzed by Machine Learning Methods. | Neuropsychiatr Dis Treat | 2025 | 40969397 | PubTator, text mining | PubMed |
| Capacitive Sensors for Label-Free Detection in High-Ionic-Strength Bodily Fluids: A Review. | Biosensors (Basel) | 2025 | 40862952 | PubTator, text mining | PubMed |
| A systematic review on type 3 diabetes: bridging the gap between metabolic dysfunction and Alzheimer's disease. | Diabetol Metab Syndr | 2025 | 40859375 | PubTator, text mining | PubMed |
| Cell-specific copper dyshomeostasis mechanism in Alzheimer's disease. | Transl Neurodegener | 2025 | 40847318 | PubTator, text mining | PubMed |
| Dataset on insight into inhibition capacity of cyclic tetra-amino acid based compounds as efficient crystal structure of human insulin-degrading enzyme inhibitors. | Data Brief | 2025 | 40837479 | PubTator, text mining | PubMed |
| Dietary formaldehyde: a silent aggravator of diabetes and cognitive impairments. | Nutr Diabetes | 2025 | 40830331 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3416/papers?page=2